Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × INDUSTRY × Cognitive Dysfunction × Clear all

Phase

Status

Completed 4 Active not recruiting 2 Withdrawn 1 Unknown 1 Enrolling by invitation 1

Sponsor Class

OTHER 22 OTHER_GOV 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 155 Carcinoma, Non-Small-Cell Lung 146 Breast Neoplasms 144 Colorectal Neoplasms 86 Stomach Neoplasms 72 Pancreatic Neoplasms 65 Prostatic Neoplasms 63 Lung Neoplasms 62 Neoplasm Metastasis 58 Melanoma 58 Recurrence 56 Leukemia, Myeloid, Acute 56 Multiple Myeloma 55 Carcinoma, Hepatocellular 55 Ovarian Neoplasms 53 Lymphoma 47 Advanced Solid Tumor 47 Advanced Solid Tumors 46 Solid Tumor 42 Uterine Cervical Neoplasms 38 Lymphoma, Non-Hodgkin 35 Glioblastoma 35 Colonic Neoplasms 34 Leukemia 33 Lymphoma, B-Cell 31 Esophageal Neoplasms 27 Urinary Bladder Neoplasms 26 Precursor Cell Lymphoblastic Leukemia-Lymphoma 26 Head and Neck Neoplasms 26 Brain Neoplasms 26

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04972019 2022-05-02

TCIFCF

Bright Cloud International Corp

Phase NA Unknown

Breast Neoplasms, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡